The protective role of EMILIN-1 was further validated in a HER2-driven breast cancer model by crossing Emilin1−/− mice with MMTV-Δ16HER2 transgenic mice that spontaneously develop multifocal mammary adenocarcinomas. This evidence concerns the gene EMILIN1 and breast carcinoma.